These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 27609280)
1. Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis. Cosentino M; Zaffaroni M; Legnaro M; Bombelli R; Schembri L; Baroncini D; Bianchi A; Clerici R; Guidotti M; Banfi P; Bono G; Marino F J Neuroimmunol; 2016 Sep; 298():82-9. PubMed ID: 27609280 [TBL] [Abstract][Full Text] [Related]
2. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy. Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872 [TBL] [Abstract][Full Text] [Related]
3. Levels of mRNA for dopaminergic receptor D₅ in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis. Cosentino M; Zaffaroni M; Marino F J Neuroimmunol; 2014 Dec; 277(1-2):193-6. PubMed ID: 25468276 [TBL] [Abstract][Full Text] [Related]
4. Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis. Zaffaroni M; Marino F; Bombelli R; Rasini E; Monti M; Ferrari M; Ghezzi A; Comi G; Lecchini S; Cosentino M Exp Neurol; 2008 Dec; 214(2):315-21. PubMed ID: 18824168 [TBL] [Abstract][Full Text] [Related]
5. Dataset of mRNA levels for dopaminergic receptors, adrenoceptors and tyrosine hydroxylase in lymphocytes from subjects with clinically isolated syndromes. Cosentino M; Zaffaroni M; Legnaro M; Bombelli R; Schembri L; Baroncini D; Bianchi A; Clerici R; Guidotti M; Banfi P; Bono G; Marino F Data Brief; 2016 Dec; 9():376-381. PubMed ID: 27699190 [TBL] [Abstract][Full Text] [Related]
6. Dopamine, T cells and multiple sclerosis (MS). Levite M; Marino F; Cosentino M J Neural Transm (Vienna); 2017 May; 124(5):525-542. PubMed ID: 28283756 [TBL] [Abstract][Full Text] [Related]
7. cAMP levels in lymphocytes and CD4 Cosentino M; Kustrimovic N; Ferrari M; Rasini E; Marino F Immunology; 2018 Mar; 153(3):337-341. PubMed ID: 28940477 [TBL] [Abstract][Full Text] [Related]
8. Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects. Cosentino M; Ferrari M; Kustrimovic N; Rasini E; Marino F Hum Immunol; 2015 Oct; 76(10):747-52. PubMed ID: 26429319 [TBL] [Abstract][Full Text] [Related]
9. Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity. Leite F; Lima M; Marino F; Cosentino M; Ribeiro L PLoS One; 2016; 11(1):e0147483. PubMed ID: 26808524 [TBL] [Abstract][Full Text] [Related]
10. High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS. Jurewicz A; Zaleski K; Domowicz M; Selmaj K J Neuroimmunol; 2014 Nov; 276(1-2):187-94. PubMed ID: 25242631 [TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Link J Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782 [TBL] [Abstract][Full Text] [Related]
12. The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Mirabella M; Tonali PA; Batocchi AP J Neuroimmunol; 2008 Dec; 205(1-2):126-34. PubMed ID: 18926576 [TBL] [Abstract][Full Text] [Related]
13. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line. Bahbouhi B; Berthelot L; Pettré S; Michel L; Wiertlewski S; Weksler B; Romero IA; Miller F; Couraud PO; Brouard S; Laplaud DA; Soulillou JP J Leukoc Biol; 2009 Nov; 86(5):1049-63. PubMed ID: 19696154 [TBL] [Abstract][Full Text] [Related]
14. Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells. Schlöder J; Berges C; Luessi F; Jonuleit H Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134847 [TBL] [Abstract][Full Text] [Related]
15. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400 [TBL] [Abstract][Full Text] [Related]
16. Gene expression analysis of histamine receptors in peripheral blood mononuclear cells from individuals with clinically-isolated syndrome and different stages of multiple sclerosis. Costanza M; Di Dario M; Steinman L; Farina C; Pedotti R J Neuroimmunol; 2014 Dec; 277(1-2):186-8. PubMed ID: 25293806 [TBL] [Abstract][Full Text] [Related]
17. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients. Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669 [TBL] [Abstract][Full Text] [Related]
18. Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells. Trinschek B; Luessi F; Gross CC; Wiendl H; Jonuleit H Int J Mol Sci; 2015 Jul; 16(7):16330-46. PubMed ID: 26193267 [TBL] [Abstract][Full Text] [Related]
19. Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta. Giorelli M; Livrea P; Trojano M J Interferon Cytokine Res; 2005 Jul; 25(7):395-406. PubMed ID: 16022584 [TBL] [Abstract][Full Text] [Related]
20. Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. Putheti P; Pettersson A; Soderstrom M; Link H; Huang YM J Clin Immunol; 2004 Mar; 24(2):155-61. PubMed ID: 15024182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]